Search Results - "Seroneit, T."

Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial by Lorenzen, S., Hentrich, M., Haberl, C., Heinemann, V., Schuster, T., Seroneit, T., Roethling, N., Peschel, C., Lordick, F.

“…Background: Phase II and III trials of docetaxel, cisplatin and fluorouracil (DCF) have shown superior efficacy versus cisplatin and fluorouracil alone but…”
Get full text

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer by LORDICK, F, LORENZEN, S, SERONEIT, T, BREDENKAMP, R, DUYSTER, J, PESCHEL, C, STOLLFUSS, J, VEHLING-KAISER, U, KULLMANN, F, HENTRICH, M, ZUMSCHLINGE, R, DIETZFELBINGER, H, THOEDTMANN, J, HENNIG, M

“…Oxaliplatin plus fluorouracil/folinic acid (5-FU/FA) every 2 weeks has shown promising activity in advanced gastric cancer. This study assessed the efficacy…”
Get full text

Effects of X- and UV-irradiation on proteins by Durchschlag, H., Fochler, C., Feser, B., Hausmann, S., Seroneit, T., Swientek, M., Swoboda, E., Winklmair, A., Wlček, C., Zipper, P.

“…The radiation damage of several proteins has been investigated in aqueou solution, after preceding X- or UV-irradiation. In order to differentiate between…”
Get full text

Docetaxel, cisplatin and leucovorin/fluorouracil in first-line advanced gastric cancer and adenocarcinoma of the esophagogastric junction: Results of the phase II GASTRO-TAX-1 trial by Lorenzen, S., Weigert, N., Heinemann, V., Hentrich, M., Schuster, T., Seroneit, T., Röthling, N., Peschel, C., Lordick, F.

“…Abstract only 4561 Background: Phase II and III trials combining docetaxel, cisplatin and fluorouracil (DCF) every 3 weeks (wks) have shown superior efficacy…”
Get full text

Oxaliplatin plus 5FU/folinic acid (FUFOX Regimen) in 1 st line metastatic gastric cancer (MGC). Results of the Multicenter Phase II STOMOX Trial by Duyster, J., Lorenzen, S., Kullmann, F., Hentrich, M., Zumschlinge, R., Vehling-Kaiser, U., Seroneit, T., Bredenkamp, R., Peschel, C., Lordick, F.

“…Abstract only…”
Get full text

Phase I trial of continous infusion 5-fluorouracil (CI-5FU) and escalating doses of oxaliplatin (OXA) given weekly with concurrent radiation (RT) in locally advanced esophageal squamous cell carcinoma (ESCC) by Brücher, B. L., Zimmermann, F., Riera, J., Becker, K., Roethling, N., Seroneit, T., Molls, M., Peschel, C., Siewert, J. R., Lordick, F.

“…Abstract only…”
Get full text